The obligate intracellular parasite, Toxoplasma gondii, modulates host immunity in a variety of highly specific ways. Previous work revealed a polymorphic, injected parasite factor, ROP16, to be a key virulence determinant and regulator of host cell transcription. These properties were shown to be partially mediated by dysregulation of the host transcription factors STAT3 and STAT6, but the molecular mechanisms underlying this phenotype were unclear. Here, we use a Type I Toxoplasma strain deficient in ROP16 to show that ROP16 induces not only sustained activation but also an extremely rapid (within 1 min) initial activation of STAT6. Using recombinant wild-type and kinase-deficient ROP16, we demonstrate in vitro that ROP16 has intrinsic tyrosine kinase activity and is capable of directly phosphorylating the key tyrosine residue for STAT6 activation, Tyr 641 . Furthermore, ROP16 co-immunoprecipitates with STAT6 from infected cells. Taken together, these data strongly suggest that STAT6 is a direct substrate for ROP16 in vivo.Toxoplasma gondii, a ubiquitous, intracellular parasite of the phylum Apicomplexa, infects an estimated one-third of the human population as well as a broad range of warm-blooded animals. Infection is typically asymptomatic and chronic; however, severe and even fatal disease can result from acute infections of congenitally infected or immunocompromised hosts. Strikingly, Toxoplasma-induced inflammatory pathology in adult immunocompetent patients has also been reported (1, 2).Understanding the host/parasite interactions that underpin these various disease manifestations has become an area of active investigation, and recent work has implicated as key players a set of polymorphic proteins that are secreted from the apical organelles known as rhoptries (3). One of these, a putative serine-threonine kinase known as ROP16, was revealed as a parasite factor responsible for many changes in host gene expression (4). Much of the effect of ROP16 on transcription was found to depend on sustained activation of STAT3 and STAT6, two host transcription factors that can negatively regulate Th1 inflammatory responses. ROP16 is thus poised to mediate the inflammatory status of the host, an intriguing role for a parasite effector because Th1-driven immunopathology, not just uncontrolled parasite growth and dissemination, has been proposed to be a significant contributor to the disease outcome (5).Although the potential significance of the ROP16 effect on STATs is clear, the molecular mechanism by which it accomplishes this sustained activation was not apparent from the initial studies. STAT activation requires phosphorylation at specific, conserved tyrosine residues; this phosphorylation, which induces dimerization and nuclear translocation of the STATs, is canonically initiated and maintained in the cytosol by either receptorassociated tyrosine kinases (such as the JAKs) or non-receptor tyrosine kinases (e.g. Src family kinases) (6). The duration of STAT activation is usually limited by negative feedback beca...